Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.1195
-0.0006 (-0.50%)
At close: May 12, 2025, 4:00 PM
0.1190
-0.0005 (-0.42%)
After-hours: May 12, 2025, 7:59 PM EDT
Petros Pharmaceuticals Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Petros Pharmaceuticals.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Petros Pharmaceuticals.
Recommendation Trends
Rating | Dec '23 |
---|---|
Strong Buy | 0 |
Buy | 0 |
Hold | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +83,582.01% | Dec 8, 2023 |
Financial Forecast
Revenue This Year
5.59M
from 5.11M
Increased by 9.25%
Revenue Next Year
5.56M
from 5.59M
Decreased by -0.41%
EPS This Year
-1.11
from -83.47
EPS Next Year
-1.12
from -1.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.7M | 5.7M | 11.6M | ||
Avg | 5.6M | 5.6M | 11.3M | ||
Low | 5.4M | 5.3M | 10.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 12.5% | 2.5% | 108.7% | ||
Avg | 9.3% | -0.4% | 102.8% | ||
Low | 5.0% | -4.3% | 94.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.14 | -1.16 | -0.74 | ||
Avg | -1.11 | -1.12 | -0.71 | ||
Low | -1.07 | -1.08 | -0.69 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.